HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Lansoprazole

TERMINATED · PHASE4 · Patients Undergoing Elective Coronary Artery Bypass Graft

Recruitment slow

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.